“IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA” (2025) Frontier in Medical and Health Research, 3(10), pp. 570–577. Available at: https://fmhr.net/index.php/fmhr/article/view/1765 (Accessed: 10 November 2026).